News

For income investors, few things are as rewarding as receiving quarterly dividend payouts. But the next best thing very well might be learning that the stocks in their yield-focused portfolio are

In the current market climate, investors are navigating a landscape marked by near-complete uncertainty. With the Nasdaq experiencing a correction and geopolitical tensions creating ripples across

While the health care sector has struggled this year, that hasn’t been the case for all of Big Pharma.

Shares of New Jersey-based Merck & Co. (NYSE: MRK) have outperformed the sector and the

A paradox is unfolding for one of the world's most recognized financial titans. Shares of Mastercard (NYSE: MA) have stumbled more than 15% year to date, with recent selling pressure intensified

Within many parts of the stock market, investors have had a rough go of it so far in 2026. The S&P 500 is down over 5% on the year, and the index is not far off from being down 10% from its

The Magnificent 7 account for roughly a third of the entire S&P 500, so it's understandable that some investors might consider focusing an outsized portion of their portfolio on either one of

Last week, the Nasdaq and Dow entered corrections, further dragging down some of the largest stocks in their respective indices. For the tech-heavy Nasdaq, one of those was Alphabet (NASDAQ:

MercadoLibre (NASDAQ: MELI), often referred to as the Amazon (NYSE: AMZN) of Latin America, may be approaching discount territory. The stock has fallen almost 40% from its all-time high and is

PDD (NASDAQ: PDD) is one of many stocks that have experienced a significant downturn over recent months. The stock is down over 25% from its 52-week high, reached in November 2025, and has fallen